Leading countries in global life sciences mergers and acquisitions based on deal number in 2019
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical research and development
Overview
6
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Premium Statistic R&D spending growth worldwide on pharmaceuticals 2015-2028
- Premium Statistic Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
- Premium Statistic Number of drugs in the R&D pipeline worldwide 2001-2024
- Basic Statistic Pharma companies worldwide with active R&D pipelines 2001-2024
- Basic Statistic Projected most valuable R&D projects based on net present value 2023
R&D performance by company
5
- Premium Statistic R&D spending share of top pharmaceutical companies 2022
- Basic Statistic Top pharmaceutical companies in R&D spending growth 2022
- Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Premium Statistic Distribution of pharmaceutical R&D companies by region 2023 vs. 2024
Characteristics of R&D pipeline
5
- Basic Statistic Top therapeutic categories worldwide 2024, by number of R&D products
- Premium Statistic Worldwide top diseases 2024, by number of active drugs
- Basic Statistic Worldwide top origins for pipeline drugs by number of active drugs 2024
- Basic Statistic Worldwide pipeline drugs by delivery route share 2023 vs. 2024
- Basic Statistic Worldwide top drug producing mechanisms of action by number of active compounds 2024
Duration, cost and ROI
4
- Basic Statistic Average length of a clinical trial cycle 2014-2022
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Premium Statistic Average R&D cost to develop new biopharma compound 2013-2022
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2022
Outsourced R&D
4
Public opinion/knowledge
6
- Basic Statistic Willingness to pay more taxes for additional medical research - U.S. adults 2019-2023
- Basic Statistic View of health research as a problem or solution for rising costs - U.S. adults 2020
- Basic Statistic Importance to support private investments in medical research by government 2022
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Basic Statistic Share of U.S. adults who could name a medical or health research entity 2024
- Basic Statistic Participation in clinical trials recommended by a doctor among U.S. adults 2021
Further related statistics
20
- Life sciences' leading M&A deals worldwide H1 2018
- Pharma and life sciences executives' workforce strategy priorities U.S. 2020
- Healthcare deals quarterly number U.S. 2019-2020, by industry
- Forecast of CAGR global pharmaceutical industry by region 2015-2018
- Value of top 10 yet to close pharmaceutical deals Q1 2017
- Changes in forward P/E ratios in the pharmaceutical industry 2015-2016
- Impact of U.S. biopharmaceutical industry on employment 2020
- Biopharmaceutical industry impact on added value U.S. 2020
- Biopharmaceutical industry impact on output U.S. 2020
- Companies in Australia's medtech and pharma sectors 2017
- Revenue value from biotechnology companies in Germany 2008-2022
- Number of active clinical trials and studies in Australia by therapeutic class 2014
- Biopharmaceutical industry impact on labor income U.S. 2020
- 5-year life sciences employment growth in the U.S. by cluster 2018
- Market and growth of global life sciences by sector 2016
- Share of life sciences employees in the UK in 2021, by region
- Number of life sciences companies established in Israel 2009-2018
- Total value of healthcare financing deals in the U.S. in Q4 2020, by top states
- Number of life sciences companies in Israel 2018, by stage
- Share who would use chatbot for stress, anxiety and depression in Sweden 2018, by age
Further Content: You might find this interesting as well
Statistics
- Life sciences' leading M&A deals worldwide H1 2018
- Pharma and life sciences executives' workforce strategy priorities U.S. 2020
- Healthcare deals quarterly number U.S. 2019-2020, by industry
- Forecast of CAGR global pharmaceutical industry by region 2015-2018
- Value of top 10 yet to close pharmaceutical deals Q1 2017
- Changes in forward P/E ratios in the pharmaceutical industry 2015-2016
- Impact of U.S. biopharmaceutical industry on employment 2020
- Biopharmaceutical industry impact on added value U.S. 2020
- Biopharmaceutical industry impact on output U.S. 2020
- Companies in Australia's medtech and pharma sectors 2017
- Revenue value from biotechnology companies in Germany 2008-2022
- Number of active clinical trials and studies in Australia by therapeutic class 2014
- Biopharmaceutical industry impact on labor income U.S. 2020
- 5-year life sciences employment growth in the U.S. by cluster 2018
- Market and growth of global life sciences by sector 2016
- Share of life sciences employees in the UK in 2021, by region
- Number of life sciences companies established in Israel 2009-2018
- Total value of healthcare financing deals in the U.S. in Q4 2020, by top states
- Number of life sciences companies in Israel 2018, by stage
- Share who would use chatbot for stress, anxiety and depression in Sweden 2018, by age
KPMG. (January 29, 2020). Leading countries in global life sciences mergers and acquisitions based on deal number in 2019 [Graph]. In Statista. Retrieved May 19, 2024, from https://www.statista.com/statistics/398229/leading-countries-by-pharmaceutical-industry-mergers-and-acquisitions/
KPMG. "Leading countries in global life sciences mergers and acquisitions based on deal number in 2019." Chart. January 29, 2020. Statista. Accessed May 19, 2024. https://www.statista.com/statistics/398229/leading-countries-by-pharmaceutical-industry-mergers-and-acquisitions/
KPMG. (2020). Leading countries in global life sciences mergers and acquisitions based on deal number in 2019. Statista. Statista Inc.. Accessed: May 19, 2024. https://www.statista.com/statistics/398229/leading-countries-by-pharmaceutical-industry-mergers-and-acquisitions/
KPMG. "Leading Countries in Global Life Sciences Mergers and Acquisitions Based on Deal Number in 2019." Statista, Statista Inc., 29 Jan 2020, https://www.statista.com/statistics/398229/leading-countries-by-pharmaceutical-industry-mergers-and-acquisitions/
KPMG, Leading countries in global life sciences mergers and acquisitions based on deal number in 2019 Statista, https://www.statista.com/statistics/398229/leading-countries-by-pharmaceutical-industry-mergers-and-acquisitions/ (last visited May 19, 2024)
Leading countries in global life sciences mergers and acquisitions based on deal number in 2019 [Graph], KPMG, January 29, 2020. [Online]. Available: https://www.statista.com/statistics/398229/leading-countries-by-pharmaceutical-industry-mergers-and-acquisitions/